Publications by authors named "Juan E Basilio Flores"

Background: Multimodal therapy for brain arteriovenous malformations (bAVM) with embolization followed by stereotactic radiosurgery (E + SRS) has shown varying outcomes. Its benefits over other treatment modalities have been questioned. The goal of this systematic review was to determine the factors associated with cure and complication rates of this treatment strategy.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aims to describe the clinical and angiographic traits of brain arteriovenous malformations (bAVM) based on their specific locations, which are important for prognosis and treatment decisions.
  • - Researchers analyzed data from 269 bAVM cases at a national referral hospital from 2010 to 2020, categorizing them into eight location groups: frontal, temporal, parieto-occipital, periventricular, deep, cerebellar, brainstem, and mixed.
  • - Significant differences were found among the groups in various aspects including clinical presentation, size and density of the bAVM, and characteristics of blood vessels involved, leading to the development of location-specific profiles for these conditions.
View Article and Find Full Text PDF

Introduction: Embolization with the intention to cure has not been well studied in ruptured arteriovenous malformations (AVMs). Furthermore, the role of primary curative embolization of pediatric AVMs is uncertain. Hence, we aimed to characterize the safety and efficacy of curative embolization of ruptured pediatric AVMs and assess predictors of obliteration and complications.

View Article and Find Full Text PDF

Multiple brain arteriovenous malformations (bAVM) are rare neurovascular lesions usually related to genetic syndromes. Its management is not well established given its rarity. The objective of this study was to describe the clinical and angiographic features of published cases and to explore their associations with treatment outcomes.

View Article and Find Full Text PDF

Background: Stable angina pectoris is a chronic medical condition with significant impact on mortality and quality of life; it can be macrovascular or microvascular in origin. Ranolazine is a second-line anti-anginal drug approved for use in people with stable angina. However, the effects of ranolazine for people with angina are considered to be modest, with uncertain clinical relevance.

View Article and Find Full Text PDF